“We are impressed with the study outcomes and performance of Ibex Breast, which were in near perfect concordance with the consensus diagnosis between pathologists. Our team demonstrated that Ibex’s AI technology goes beyond diagnosing cancer and provides accurate insights on the type of invasive carcinomas, the nuclear grading of in situ carcinomas and more. I’m confident that AI will provide benefit to cancer patients across the diagnostic workflow”
Anne Vincent-Salomon, MD
Share this article:
Share this article:
Subscribe to our newsletter:
By providing my details I agree that my data will be handled in accordance with IBEX Privacy Policy.
About IBEX
IBEX is the leader in AI-powered cancer diagnostics in pathology. We empower physicians to provide every patient with an accurate, timely and personalized cancer diagnosis. Our AI platform is deployed worldwide, supporting pathologists and providers with AI-insights that help improve the quality and accuracy of diagnosis, reduce turnaround times and boost productivity.
Subscribe to our newsletter:
By providing my details I agree that my data will be handled in accordance with IBEX Privacy Policy.